Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的
该每年接受全血细胞计数检查,以监测骨髓发育
良
继发性白血病的发生迹象。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的
该每年接受全血细胞计数检查,以监测骨髓发育
良
继发性白血病的发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运造成的标本质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦代表本软件的观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受全血细胞计数检查,以监测骨髓发育不良
继发性白血病的发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运输不当造成的标本质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生成,部分人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者
治疗应该每年接受全血细胞计数检查,以监测骨髓发育不良
继发性白血病
发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床本采集和运输不当造
本质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生,部分未经过人工审核,其表达内容亦不代表本软件
观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受全血细
检查,以监测骨髓发育不良
继发性白血病的发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,临床标本采集和运输不当造成的标本质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受全血细胞计数检查,以监测骨髓发育不良
继发
白血病的发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运输不当造成的标本质量问题占72。
声明:以上例句、词均由互联网资源自动生成,部
未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受全血细胞计
检查,以监测骨髓发育不良
继发性白血病的发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运输不当造成的标本质量问题占72。
声明:以上例句、词性分类均由互源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受全血细
检查,以监测骨髓发育不良
继发性白血病的发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,临床标本采集和运输不当造成的标本质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受全血
数检查,以监测骨髓发育不良
继发性白血病的发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其床标本采集和运输不当造成的标本质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂
治疗应该每年接受全血细胞计数检查,
骨髓
育不良
继
性白血病
迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运输不当造成标本质量问题占72。
声明:上例句、词性分类均由互联网资源自动
成,部分未经过人工审核,其表达内容亦不代表本软件
观点;若
现问题,欢迎向我们指正。